RL

Raju Lakshmipathy Mantena

Active Director Director DIN 11991859
DIN 11991859 First appointment Oct 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Raju Lakshmipathy Mantena

Raju Lakshmipathy Mantena is a Director at Avyxa Pharma India Private Limited (since 2026).

DIN 11991859
Primary Designation Director
First Appointment 07 Oct 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avyxa Pharma India Private Limited U21000TS2026FTC224078
Director07 Oct 20262026Active

Board colleagues of Raju Lakshmipathy Mantena

Directorship timeline

Open interactive timeline →
Avyxa Pharma India Private Limited
Premium access

Shareholding and investment profile for Raju Lakshmipathy Mantena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Lakshmipathy Mantena

Raju Lakshmipathy Mantena currently holds 1 directorship: Avyxa Pharma India Private Limited (Director, since 07 Oct 2026).

Raju Lakshmipathy Mantena was first appointed on 07 Oct 2026 as Director at Avyxa Pharma India Private Limited.

The current boards of Raju Lakshmipathy Mantena's companies include Mandapakala Neelalohita (Avyxa Pharma India Private Limited), Mukteeshwar Gande (Avyxa Pharma India Private Limited), Nageswara Rao Muntha Venkata (Avyxa Pharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available